cyclohexanol has been researched along with Ambulation Disorders, Neurologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borea, PA; Canazza, I; De Luca, MA; Marti, M; Ossato, A; Rimondo, C; Serpelloni, G; Trapella, C; Varani, K; Vincenzi, F | 1 |
| Hajós, M; Hoffmann, WE; Kocsis, B | 1 |
2 other study(ies) available for cyclohexanol and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice.
Topics: Animals; Anisoles; Brain; Cells, Cultured; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Feedback, Sensory; Gait Disorders, Neurologic; Humans; Hypothermia; Indoles; Male; Mice; Mice, Inbred ICR; Naphthalenes; Nervous System Diseases; Pain Threshold; Reflex, Acoustic; Spleen; Vision, Ocular | 2016 |
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.
Topics: Acoustic Stimulation; Action Potentials; Animals; Biological Clocks; Brain; Cyclohexanols; Disease Models, Animal; Electroencephalography; Evoked Potentials, Auditory; Fourier Analysis; Gait Disorders, Neurologic; Male; Maximum Tolerated Dose; Neural Pathways; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Wakefulness | 2008 |